166 related articles for article (PubMed ID: 34680201)
21. Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance.
Carretero FJ; Del Campo AB; Flores-Martín JF; Mendez R; García-Lopez C; Cozar JM; Adams V; Ward S; Cabrera T; Ruiz-Cabello F; Garrido F; Aptsiauri N
Cancer Immunol Immunother; 2016 Jan; 65(1):47-59. PubMed ID: 26611618
[TBL] [Abstract][Full Text] [Related]
22. Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.
Paschen A; Méndez RM; Jimenez P; Sucker A; Ruiz-Cabello F; Song M; Garrido F; Schadendorf D
Int J Cancer; 2003 Mar; 103(6):759-67. PubMed ID: 12516095
[TBL] [Abstract][Full Text] [Related]
23. LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.
Yeung JT; Hamilton RL; Ohnishi K; Ikeura M; Potter DM; Nikiforova MN; Ferrone S; Jakacki RI; Pollack IF; Okada H
Clin Cancer Res; 2013 Apr; 19(7):1816-26. PubMed ID: 23401227
[TBL] [Abstract][Full Text] [Related]
24. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
McGranahan N; Rosenthal R; Hiley CT; Rowan AJ; Watkins TBK; Wilson GA; Birkbak NJ; Veeriah S; Van Loo P; Herrero J; Swanton C;
Cell; 2017 Nov; 171(6):1259-1271.e11. PubMed ID: 29107330
[TBL] [Abstract][Full Text] [Related]
25. Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas.
Maleno I; Lopez Nevot MA; Seliger B; Garrido F
Int J Cancer; 2004 Apr; 109(4):636-8. PubMed ID: 14991587
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer.
Zhou YF; Xiao Y; Jin X; Di GH; Jiang YZ; Shao ZM
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34615706
[TBL] [Abstract][Full Text] [Related]
27. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.
Hu N; Clifford RJ; Yang HH; Wang C; Goldstein AM; Ding T; Taylor PR; Lee MP
BMC Genomics; 2010 Oct; 11():576. PubMed ID: 20955586
[TBL] [Abstract][Full Text] [Related]
28. Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia.
McEvoy CR; Morley AA; Firgaira FA
Genes Chromosomes Cancer; 2003 Jul; 37(3):321-5. PubMed ID: 12759931
[TBL] [Abstract][Full Text] [Related]
29. High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis.
Koene GJ; Arts-Hilkes YH; van der Ven KJ; Rozemuller EH; Slootweg PJ; de Weger RA; Tilanus MG
Tissue Antigens; 2004 Oct; 64(4):452-61. PubMed ID: 15361122
[TBL] [Abstract][Full Text] [Related]
30. A machine learning algorithm with subclonal sensitivity reveals widespread pan-cancer human leukocyte antigen loss of heterozygosity.
Pyke RM; Mellacheruvu D; Dea S; Abbott CW; McDaniel L; Bhave DP; Zhang SV; Levy E; Bartha G; West J; Snyder MP; Chen RO; Boyle SM
Nat Commun; 2022 Apr; 13(1):1925. PubMed ID: 35414054
[TBL] [Abstract][Full Text] [Related]
31. Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes.
Hsieh CH; Hsu YJ; Chang CC; Liu HC; Chuang KL; Chuang CK; Pang ST; Hasumi K; Ferrone S; Liao SK
Cancer Immunol Immunother; 2009 Mar; 58(3):395-408. PubMed ID: 18704411
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors.
Kryh H; Carén H; Erichsen J; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
BMC Genomics; 2011 Sep; 12():443. PubMed ID: 21899760
[TBL] [Abstract][Full Text] [Related]
33. Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviations.
Geertsen R; Böni R; Blasczyk R; Romero P; Betts D; Rimoldi D; Hong X; Laine E; Willers J; Dummer R
Int J Cancer; 2002 May; 99(1):82-7. PubMed ID: 11948496
[TBL] [Abstract][Full Text] [Related]
34. Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations.
Saeki H; Kitao H; Yoshinaga K; Nakanoko T; Kubo N; Kakeji Y; Morita M; Maehara Y
Clin Cancer Res; 2011 Apr; 17(7):1731-40. PubMed ID: 21325068
[TBL] [Abstract][Full Text] [Related]
35. HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape.
Perea F; Sánchez-Palencia A; Gómez-Morales M; Bernal M; Concha Á; García MM; González-Ramírez AR; Kerick M; Martin J; Garrido F; Ruiz-Cabello F; Aptsiauri N
Oncotarget; 2018 Jan; 9(3):4120-4133. PubMed ID: 29423109
[TBL] [Abstract][Full Text] [Related]
36. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
Rodriguez T; Méndez R; Roberts CH; Ruiz-Cabello F; Dodi IA; López Nevot MA; Paco L; Maleno I; Marsh SG; Pawelec G; Garrido F
Cancer Immunol Immunother; 2005 Feb; 54(2):141-8. PubMed ID: 15592718
[TBL] [Abstract][Full Text] [Related]
37. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors.
Jiménez P; Cantón J; Collado A; Cabrera T; Serrano A; Real LM; García A; Ruiz-Cabello F; Garrido F
Int J Cancer; 1999 Sep; 83(1):91-7. PubMed ID: 10449614
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide identification of copy neutral loss of heterozygosity reveals its possible association with spatial positioning of chromosomes.
Kim H; Suyama M
Hum Mol Genet; 2023 Mar; 32(7):1175-1183. PubMed ID: 36349694
[TBL] [Abstract][Full Text] [Related]
39. Integrated investigation of the prognostic role of HLA LOH in advanced lung cancer patients with immunotherapy.
Zhang X; Tang H; Luo H; Lu H; Pan C; Yu H; Zhang L; Guan Y; Yu L; Chu H; Chen J; Wang J
Front Genet; 2022; 13():1066636. PubMed ID: 36531232
[TBL] [Abstract][Full Text] [Related]
40. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
